Skip to main content

Cidara Therapeutics, Inc.

CDTXDelisted Jan 7, 2026
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001610618

Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.

13F holders, Q1 2022

Institutional positions in Cidara Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−9 vs. Q4 2021
Shares held
30.3M
−780.2K (−2.5%) vs. Q4 2021
Total value
$25.2M
−$14.2M (−36.1%) vs. Q4 2021
New holders
4
14 more added
Sold out
13
14 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 44 institutions
Q1 2021: 62 institutionsQ2 2021: 55 institutionsQ3 2021: 50 institutionsQ4 2021: 53 institutionsQ1 2022: 44 institutionsQ2 2022: 46 institutionsQ3 2022: 42 institutionsQ4 2022: 42 institutionsQ1 2023: 54 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 51 institutionsQ1 2024: 50 institutionsQ2 2024: 26 institutionsQ3 2024: 27 institutionsQ4 2024: 40 institutionsQ1 2025: 46 institutionsQ2 2025: 109 institutionsQ3 2025: 173 institutionsQ4 2025: 255 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $25.2M
Q1 2021: $56.6MQ2 2021: $40.5MQ3 2021: $42.1MQ4 2021: $39.5MQ1 2022: $25.2MQ2 2022: $13.3MQ3 2022: $17.1MQ4 2022: $20.2MQ1 2023: $34.4MQ2 2023: $29.7MQ3 2023: $22.7MQ4 2023: $18.4MQ1 2024: $20.3MQ2 2024: $16.9MQ3 2024: $35.6MQ4 2024: $183.6MQ1 2025: $205.9MQ2 2025: $1.26BQ3 2025: $3.11BQ4 2025: $7.36BQ1 2026: $0Q2 2026: $0
Institutions holding CDTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025255$7.36B
Q3 2025173$3.11B
Q2 2025109$1.26B
Q1 202546$205.9M
Q4 202440$183.6M
Q3 202427$35.6M
Q2 202426$16.9M
Q1 202450$20.3M
Q4 202351$18.4M
Q3 202352$22.7M
Q2 202352$29.7M
Q1 202354$34.4M
Q4 202242$20.2M
Q3 202242$17.1M
Q2 202246$13.3M
Q1 202244$25.2M
Q4 202153$39.5M
Q3 202150$42.1M
Q2 202155$40.5M
Q1 202162$56.6M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding CDTX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
JPMorgan Chase & Co122$00.00%−10,095−98.8%Reduced
Simplex Trading, LLC636$00.00%−2,410−79.1%Reduced
Wells Fargo & Company353$00.00%+1+0.3%Added
BNP Paribas Arbitrage, SA353$2940.00%−183−34.1%Reduced
Allworth Financial LP800$1.00K0.00%00.0%Unchanged
UBS Group AG1,725$1.00K0.00%+1,714+15,581.8%Added
Morgan Stanley2,500$2.00K0.00%+829+49.6%Added
Bollard Group LLC7,733$6.00K0.00%00.0%Unchanged
Pacifica Partners Inc.8,000$6.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)8,601$7.00K0.00%−3,304−27.8%Reduced
Shufro Rose & Co LLC10,413$9.00K0.00%+10,413New
Stratos Wealth Partners, LTD.10,489$9.00K0.00%+10,489New
Schonfeld Strategic Advisors LLC10,900$9.00K0.00%+10,900New
Occudo Quantitative Strategies LP14,522$12.0K0.00%−2,159−12.9%Reduced
Russell Investments Group, Ltd.17,100$14.0K0.00%00.0%Unchanged
Two Sigma Investments, LP20,532$17.0K0.00%−235,800−92.0%Reduced
Advisor Group Holdings, Inc.22,000$18.0K0.00%−100−0.5%Reduced
Bank of America Corp34,234$28.0K0.00%+37+0.1%Added
HSBC Holdings PLC40,131$33.0K0.00%00.0%Unchanged
Aveo Capital Partners, LLC42,502$35.0K0.01%00.0%Unchanged
Millennium Management LLC45,153$38.0K0.00%−40,629−47.4%Reduced
Barclays PLC47,425$39.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc75,273$63.0K0.00%−401−0.5%Reduced
Raymond James Financial Services Advisors, Inc.86,278$72.0K0.00%+11,243+15.0%Added
Northern Trust Corp98,393$82.0K0.00%−12,104−11.0%Reduced
Jeppson Wealth Management, LLC143,850$119.0K0.06%+33,325+30.2%Added
Two Sigma Advisers, LP154,394$129.0K0.00%−391,900−71.7%Reduced
State Street Corp176,237$147.0K0.00%+21,837+14.1%Added
Artal Group S.A.224,675$187.0K0.01%00.0%Unchanged
Bridgeway Capital Management, LLC250,000$208.0K0.00%−97,200−28.0%Reduced
West Family Investments, Inc.368,910$307.0K0.09%00.0%Unchanged
Monashee Investment Management LLC369,099$307.0K0.09%+369,099New
BlackRock Inc.380,579$317.0K0.00%+4,172+1.1%Added
Geode Capital Management, LLC476,076$396.0K0.00%+94,458+24.8%Added
Knott David M Jr579,154$482.0K0.17%+150,258+35.0%Added
Acadian Asset Management LLC1,099,299$914.0K0.00%+209,830+23.6%Added
5AM Venture Management, LLC1,134,511$945.0K0.21%00.0%Unchanged
Renaissance Technologies LLC1,437,845$1.20M0.00%+23,588+1.7%Added
Alethea Capital Management, LLC1,939,266$1.61M1.46%+2,222+0.1%Added
Vanguard Group Inc2,461,633$2.05M0.00%−15,337−0.6%Reduced
Stonepine Capital Management, LLC2,496,520$2.08M0.86%+184,990+8.0%Added
Point72 Asset Management, L.P.4,200,000$3.50M0.02%00.0%Unchanged
Nantahala Capital Management, LLC4,954,882$4.13M0.29%−315,576−6.0%Reduced
BVF Inc6,861,127$5.71M0.23%00.0%Unchanged
Laurion Capital Management LP0$00.00%−198,635−100.0%Sold out
Marshall Wace, LLP0$00.00%−146,408−100.0%Sold out
Citadel Advisors LLC0$00.00%−126,185−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−118,040−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−88,097−100.0%Sold out
XTX Topco Ltd0$00.00%−39,446−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−22,236−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−17,000−100.0%Sold out
Cetera Investment Advisers0$00.00%−12,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−11,537−100.0%Sold out
Optiver Holding B.V.0$00.00%−5,090−100.0%Sold out
Tyler-Stone Wealth Management0$00.00%−750−100.0%Sold out
Castleview Partners, LLC0$00.00%−6,986−100.0%Sold out